In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Urvish Pandya, Managing Director at Allotrope Scientific Ltd.
Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Urvish, covering:
The exponential growth of chemistry in India leading to the production of many fine Indian chemists all over the world.
Honest advice on how to deal with being made redundant as a result of being caught in the crossfire of M&A in the outsourcing space.
The role of guiding drug sponsors in finding the right CRO and CDMO match, then getting the best out of them as a partner.
The need for more modular and flexible capabilities in later stages of the drug manufacturing process.

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!
Molecule to Market is sponsored and funded by ramarketing. An international content, design and digital agency that helps companies in life sciences, get noticed.